norfloxacin and ursodeoxycholic acid

norfloxacin has been researched along with ursodeoxycholic acid in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Cotton, PB; Tarnasky, PR1
Barrioz, T; Beauchant, M; Besson, I; de Ledinghen, V; Ingrand, P; Silvain, C1
Wilcox, MH1
Beauchant, M; De Lédinghen, V; Desaint, B; Greef, M; Grollier, G; Ingrand, P; Le Sidaner, A; Legoux, JL; Moesch, C; Person, B; Sautereau, D1

Reviews

1 review(s) available for norfloxacin and ursodeoxycholic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

3 trial(s) available for norfloxacin and ursodeoxycholic acid

ArticleYear
Randomized trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin.
    Gastrointestinal endoscopy, 1995, Volume: 42, Issue:1

    Topics: Anti-Infective Agents; Bile Ducts; Cholagogues and Choleretics; Drug Therapy, Combination; Humans; Norfloxacin; Stents; Ursodeoxycholic Acid

1995
Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin.
    Lancet (London, England), 1994, Aug-27, Volume: 344, Issue:8922

    Topics: Administration, Oral; Bile Ducts; Cholestasis; Constriction, Pathologic; Drug Therapy, Combination; Humans; Norfloxacin; Stents; Ursodeoxycholic Acid

1994
Prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin: a multicenter randomized trial.
    Digestive diseases and sciences, 2000, Volume: 45, Issue:1

    Topics: Aged; Anti-Infective Agents; Cholagogues and Choleretics; Cholestasis; Female; Humans; Male; Norfloxacin; Prospective Studies; Stents; Time Factors; Treatment Outcome; Ursodeoxycholic Acid

2000

Other Studies

3 other study(ies) available for norfloxacin and ursodeoxycholic acid

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Preventing biliary stent occlusion.
    Lancet (London, England), 1994, Oct-15, Volume: 344, Issue:8929

    Topics: Bacterial Infections; Cholestasis; Drug Therapy, Combination; Humans; Norfloxacin; Stents; Ursodeoxycholic Acid

1994